Mash Compostos Plasticos to be Acquired by A. Schulman

A. Schulman, Inc. (Nasdaq: SHLM) announced today that it has agreed to purchase Mash Compostos Plasticos ("Mash"), a masterbatch additive producer and engineered plastics compounder based in Sao Paulo, Brazil.

The transaction is expected to close on November 3, 2010, pending customary closing procedures.

"Brazil is a highly attractive market for A. Schulman and is very important to our growth strategy," said Joseph M. Gingo, Chairman, President and Chief Executive Officer of A. Schulman. "It is a large, diversified market with strong macroeconomic fundamentals. The Brazilian plastics industry holds significant growth potential because per-capita consumption of plastic is still much lower than in other countries. With this acquisition, and with our April 30, 2010 acquisition of ICO, Inc., which included two facilities in Brazil, we are aggressively expanding our presence in that market and enhancing our ability to serve customers."

Gustavo Perez, General Manager and Chief Operating Officer of the Americas for A. Schulman, stated, "For the first time ever in Brazil, we will have the ability to grow our masterbatch and engineered plastics platforms. With Mash's state-of-the-art technology combined with A. Schulman's core competencies in serving these markets, we will produce specialized additives and plastic materials to meet growing demand in this region. We have been impressed with Mash's experienced management team, excellent operations and fundamental market presence."

Sergio Dulcini, Executive Director for Mash Compostos Plasticos, stated, "We are very enthusiastic about both the opportunity to offer A. Schulman's products and technologies in South America, and to produce them locally in our plant in Sao Paulo."

Target synergies from the Mash acquisition are expected to result from improving working capital management and leveraging A. Schulman's global purchasing power.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.